Clinical Trials Results - National Cancer Institute

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -7 of 7 Show results per page	View Search Criteria \| Help With Results

Last Modified: 8/1/1999 First Published: 12/1/1997


1.		Phase IV Study of Liposomal Cytarabine (DepoFoam Encapsulated Cytarabine; DTC 101) for Neoplastic Meningitis in Patients with Solid Tumors, Including Primary Brain Tumors (Summary Last Modified 08/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Closed				18 and over				Pharmaceutical / Industry				DTC-96-001 NCI-V97-1337


2.		DepoCyt Therapy in Patients With Neoplastic Meningitis From Lymphoma or a Solid Tumor

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Completed				18 and over				Pharmaceutical / Industry				SKY0101-010 NCT00029523


3.		Treatment of Acute Lymphoblastic Leukemia or Aggressive Lymphoma With Relapse in Central Nervous System With Depocyt

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				18 and over				Other				GMALL06 NCT00199108

Last Modified: 8/1/1995


4.		Phase III Randomized Study of DepoFoam-Encapsulated Cytarabine (DTC 101) vs Standard Intrathecal Therapy for Neoplastic Meningitis (Summary Last Modified 08/95)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				any age				Pharmaceutical / Industry				MSKCC-94129 NCI-V95-0661

Last Modified: 9/1/1999 First Published: 12/1/1997


5.		Phase III Study of Liposomal Cytarabine Versus Standard Therapy for Neoplastic Meningitis in Patients With Leukemia, Lymphoma, or Solid Tumors (Summary Last Modified 09/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				3 and over				Pharmaceutical / Industry				DTC-92-001 NCI-V97-1338

Last Modified: 11/26/2007 First Published: 1/1/1996


6.		Phase II Study of Delayed Craniospinal Irradiation Following 6 Months of Intensive Chemotherapy, with a Phase I Study of an "Up-Front" Therapeutic Window with Thiotepa or Sustained Release Cytarabine in Children with Isolated CNS Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				6 mo. to under 21 at relapse				NCI				POG-9412 NCT00002704, POG-9412

Last Modified: 4/1/2002 First Published: 1/1/1998


7.		Phase I Dose Escalation Study of Liposomal Cytarabine (Depofoam Encapsulated Cytarabine; DTC 101) in Pediatric Patients with Recurrent or Refractory Meningeal Malignancies (Summary Last Modified 04/2002)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				1 to 21				Pharmaceutical / Industry				SKYEPHARMA-96-002 DTC-96-002, NCI-V97-1336, NCT00003073

Select All on One Page